FDA
approval
· 2022-09-21
FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
Summary
FDA approved a supplemental application for methylphenidate hydrochloride from KVK-Tech, Inc., a generic stimulant used to treat attention-deficit/hyperactivity…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)